Pharmaceutical - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

201 to 225 of 308 results

AstraZeneca's Brilinta rolls out in India

18-10-2012

The Indian subsidiary of Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday launched its patented…

Asia-PacificAstraZenecaBrilintaCardio-vascularMarkets & MarketingPharmaceutical

AstraZeneca partners with China's Pharmaron to accelerate drug discovery

15-10-2012

Pharmaron, a China-based R&D service provider for the pharmaceutical and biotech industries with operations…

AstraZenecaLicensingPharmaceuticalPharmaronResearch

News briefs: AstraZeneca suspends share repurchasing; New CMO for Sanofi; Research facility for Octapharma

02-10-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) saw its shares dip 1.8% to £29.02 in early afternoon…

AstraZenecaFinancialManagementOctapharmaPharmaceuticalResearchSanofi

Pharmaceutical majors unite in Japan to combat H. pylori

18-09-2012

On August 31, nine pharmaceutical companies operating in Japan (Kyowa Hakko Kirin, Takeda Pharmaceutical,…

Antibiotics and Infectious diseasesAsia-PacificAstraZenecaGastro-intestinalsPharmaceuticalRegulationTakeda Pharmaceuticals

Resubmission of aripiprazole NDA accepted; AstraZeneca bond issue

12-09-2012

Danish CNS-focused drugmaker Lundbeck (LUND: DC) and Japanese partner Otsuka Pharmaceutical (TYO: 4668)…

aripiprazole depotAstraZenecaFinancialLundbeckNeurologicalNorth AmericaOtsukaPharmaceuticalRegulation

STEMI guidelines now recommend AstraZeneca's ticagrelor as first-line treatment option

30-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that ticagrelor, its oral antiplatelet…

AstraZenecaBrilintaBriliqueCardio-vascularEffientEli LillyPharmaceuticalRegulation

AstraZeneca poaches Roche exec as CEO; Gets EU approval for Zinforo

28-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning revealed that Pascal Soriot from rival Switzerland-based…

Antibiotics and Infectious diseasesAstraZenecaEuropeManagementPharmaceuticalRegulationRocheZinforo

AstraZeneca aligns with Regulus for microRNA therapeutics

16-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and US biotech firm Regulus Therapeutics have signed…

AstraZenecaBiotechnologyCardio-vascularLicensingMetabolicsPharmaceuticalRegulus Therapeutics

AstraZeneca to get $250 million-plus from OTC Nexium deal with Pfizer

15-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says it has entered into an agreement with Pfizer (NYSE:…

AstraZenecaFinancialGastro-intestinalsGlobalLicensingNexiumPfizerPharmaceutical

AstraZeneca to increase investments in Russian manufacturing plant

12-08-2012

AstraZeneca will increase the investments in the construction of its Russian drug manufacturing plant…

AstraZenecaEuropeFinancialPharmaceuticalProduction

AstraZeneca and Bristol-Myers complete diabetes alliance expansion; Lilly revises guidance

10-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that, following Bristol-Myers Squibb's…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbDiabetesEli LillyFinancialLicensingPharmaceutical

AstraZeneca/BTG abandon CytoFab for sepsis as it fails in Ph IIb

09-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has decided to halt any further development of AZD9773…

Antibiotics and Infectious diseasesAstraZenecaBTGCytoFabLicensingPharmaceuticalResearch

Drug combo better for common type of metastatic breast cancer

02-08-2012

Postmenopausal women with the most common type of metastatic breast cancer now have a new treatment option…

ArimidexAstraZenecaFaslodexOncologyPharmaceuticalResearch

AstraZeneca sales and operating profit slump in 2nd-qrt 2012

26-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN this morning reported second-quarter 2012 financial results,…

AstraZenecaFinancialPharmaceutical

UK to implement child flu vaccines program

25-07-2012

UK Health Secretary Andrew Lansley yesterday accepted recommendations from UK immunization experts to…

Anti-viralsAstraZenecaFluenzHealthcarePharmaceuticalVaccines

Updated AHA/ACCF guidelines for unstable angina include newest blood-thinning drug

18-07-2012

Ticagrelor, Anglo-Swedish drug major AstraZeneca's (LSE: AZN) blood-thinning drug Brilique/Brilinta which…

AspirinAstraZenecaBrilintaBriliqueCardio-vascularClopidogrelNorth AmericaPharmaceuticalprasugrelRegulation

Ex-AstraZeneca CEO David Brennan to forego bonus

17-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed yesterday the remuneration arrangements relating…

AstraZenecaFinancialManagementPharmaceutical

201 to 225 of 308 results

Back to top